Early white discoloration of infantile hemangioma: a sign of impending ulceration.

@article{Maguiness2010EarlyWD,
  title={Early white discoloration of infantile hemangioma: a sign of impending ulceration.},
  author={S. Maguiness and W. Hoffman and T. McCalmont and I. Frieden},
  journal={Archives of dermatology},
  year={2010},
  volume={146 11},
  pages={
          1235-9
        }
}
OBJECTIVE To evaluate the relationship between early white discoloration of infantile hemangioma (IH) and ulceration. [...] Key MethodDESIGN Retrospective cohort study. SETTING Tertiary referral center. PATIENTS A case series of 11 infants with early white discoloration of IH are described.Expand
First report of topical timolol treatment in primarily ulcerated perineal haemangioma
TLDR
The personal experience of the use of timolol, a non-selective β blocker, in two neonates with an unusual primarily ulcerated lesion of the perineum area is reported, and oral propranolol is used as a first-line systemic treatment. Expand
Infantile Haemangiomas: A Review on Treatment Modalities
TLDR
While most of the haemangiomas do not require any medical or surgical treatment, those who do, can be treated with laser therapy, surgical therapy or drug therapy with the latter mostly used to reduce morbidity, mortality and to treat complications. Expand
Alternate-day steroid therapy in an infant with a large orbital cavernous hemangioma
TLDR
A 12-month-old female infant with a large CH, affecting the right side of her face including her forehead, orbit, nose, cheek, external ear and mandible, was treated through alternate-day steroid therapy over a duration of 8 months yielding a cosmetically satisfying appearance with no adverse effects. Expand
Diagnosis and Management of Infantile Hemangioma
TLDR
This clinical report is the first based on input from individuals representing the many specialties involved in the treatment of IH to update the pediatric community regarding recent discoveries in IH pathogenesis, treatment, and clinical associations and to provide a basis for clinical decision-making in the management of Ih. Expand
Infantile hemangiomas: our current understanding and treatment options.
TLDR
Generally, uncomplicated IH can be observed up to 18 months, however, IH should be treated in the setting of bleeding, ulceration, functional compromise, or eventual failure to regress. Expand
Infantile Hemangiomas in the Head and Neck Region.
TLDR
The authors aim to provide a review of the natural history, pathology, complications, syndromes, and medical management of infantile hemangioma. Expand
Hemangiomas: new insight and medical treatment
TLDR
This is a practical review reporting the approach to IHs in the authors' daily practice, and β‐blocker therapy has become the first‐line therapy in severe and/or complicated hemangiomas. Expand
Propranolol Use in PHACE Syndrome with Cervical and Intracranial Arterial Anomalies: Collective Experience in 32 Infants
TLDR
This is the largest report thus far of patients with PHACE syndrome treated with propranolol, and although no catastrophic neurologic events occurred, serious complications, particularly severe ulcerations, were seen in a minority of patients, and given the sample size, it cannot exclude the possibility that proPRanolol could augment the risk of stroke in this population. Expand
Management of difficult infantile haemangiomas
TLDR
The authors discuss the various possible complications of infantile haemangiomas, the rationale for treatment and appropriate possible interventions, as well as some exciting new therapeutic options. Expand
Diagnosis and Management of Infantile
TLDR
This clinical report is the first based on input from individuals representing the many specialties involved in the treatment of IH to update the pediatric community regarding recent discoveries in IH pathogenesis, treatment, and clinical associations and to provide a basis for clinical decision-making in the management of Ih. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 11 REFERENCES
Differences between ulcerated and non-ulcerated hemangiomas, a retrospective study of 465 cases.
TLDR
It is concluded that larger, more superficial hemangiomas in areas more susceptible to trauma and contamination were more likely to ulcerate. Expand
Growth Characteristics of Infantile Hemangiomas: Implications for Management
TLDR
Most infantile hemangioma growth occurs before 5 months, yet 5 months was also the mean age at first visit to a specialist, and recognition of growth characteristics and factors that predict the need for follow-up could help aid in clinical decision-making. Expand
The Nasal Crease Sign in Segmental Facial Hemangioma—An Early Sign of Cartilage Destruction
TLDR
It is proposed that this ‘‘nasal crease sign’’ in infants with segmental facial hemangioma involving the nose and philtrum may be a premonitory clinical finding of impending nasal cartilage destruction. Expand
Infantile Hemangioma: Challenges, New Insights, and Therapeutic Promise
TLDR
This review summarizes the current state of knowledge about hemangioma, highlighting the proposed mechanisms that are best supported by the available data and the implications for therapeutic advances. Expand
Infantile Hemangiomas: Current Knowledge, Future Directions. Proceedings of a Research Workshop on Infantile Hemangiomas
TLDR
Ilona J. Frieden, M.D, Ph.D.,* Anita N. Haggstrom, M,D.,§ Eulalia Baselga, MD.,†† Maria C. Garzon,M.D. Expand
Hypoxia-Induced Mediators of Stem/Progenitor Cell Trafficking Are Increased in Children With Hemangioma
TLDR
Findings demonstrate that proliferating hemangiomas express known mediators of vasculogenesis and suggest that this process may play a role in the initiation or progression of this disease. Expand
Hypoxia-induced HIF-1 alpha accumulation is augmented in a co-culture of keloid fibroblasts and human mast cells: involvement of ERK1/2 and PI-3K/Akt.
TLDR
Findings suggest that under hypoxic conditions mast cells may contribute, at least in part, to an elevated expression of HIF-1alpha and VEGF protein in keloids via direct cell-cell interaction with fibroblasts. Expand
Early regressive and abnormally persistent infantile hemangiomas: learning from the extremes [abstract]. Paper presented at: The International Society for the Study of Vascular Anomalies
  • 2008
Multicenter Prospective Study of Ulcerated Hemangiomas
Hemangioma Investigator Group. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics
  • 2008
...
1
2
...